EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study

Monika Kadela-Tomanek iD, Kamil Krzykawski iD, Adrianna Halama, Robert Kubina iD

Molecules · 2023

DOI: 10.3390/molecules28186644 ↗

At a glance

Journal article in Molecules, 2023. Written by Monika Kadela-Tomanek and 3 co-authors. Institution: Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, 4 Jagiellońska Str., 41-20…. Major MEDLINE topics: Antineoplastic Agents, Head and Neck Neoplasms. Cited 6 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY 4.0). Funded by: Medical University of Silesia in Katowice, Poland.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

One of the most essential health problems is cancer, the first or second cause of death worldwide. Head and neck cancers are hard to detect due to non-specific symptoms. The treatment often relies on a combination of radio and chemotherapy. For this reason, the research of new anticancer compounds is fundamental. The natural and synthetic compounds with 1,4-naphthoquinone scaffold is characterized by high anticancer activity. The study aimed to evaluate the synthesis and anticancer activity of hybrids 1,4-naphthoquinone with thymidine derivatives. The series of compounds allows us to check the influence of the substituent in the C3′ position of the thymidine moiety on the cytotoxicity against squamous cancer cell lines (SCC-9 and SCC-25) and submandibular gland cancer (A-253). An annexin V/propidium iodide (PI) co-staining assay shows that derivatives cause the apoptotic in SCC-25 and A-253 cell lines. The molecular docking study examined the interaction between the active site of the BCL-2 protein and the hybrids.

Subjects

MeSH terms (MEDLINE)

Antineoplastic AgentsHead and Neck NeoplasmsHumansMolecular Docking SimulationThymidineCell Line, TumorDrug Screening Assays, AntitumorCell ProliferationMolecular StructureApoptosisStructure-Activity RelationshipNaphthoquinones

Author keywords

1,4-naphthoquinoneAZTapoptotichead and neck cancers

Substances

Antineoplastic AgentsThymidine1,4-naphthoquinoneNaphthoquinones

Authors and institutions

  • Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.
  • Silesia LabMed, Centre for Research and Implementation, Medical University of Silesia in Katowice, 18 Medyków Str., 40-752 Katowice, Poland.
  • Department of Pathology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Ostrogórska 30, 41-200 Sosnowiec, Poland.

ORCID profiles: Monika Kadela-Tomanek, Kamil Krzykawski, Robert Kubina

Funding

  • Medical University of Silesia in Katowice, Poland

Cite

APA

Kadela-Tomanek, M., Krzykawski, K., Halama, A., & Kubina, R. (2023). Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study. Molecules. https://doi.org/10.3390/molecules28186644

Vancouver

Kadela-Tomanek M, Krzykawski K, Halama A, Kubina R. Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study. Molecules. 2023. doi:10.3390/molecules28186644

BibTeX
@article{KadelaTomanek2023,
  author = {Kadela-Tomanek, Monika and Krzykawski, Kamil and Halama, Adrianna and Kubina, Robert},
  title = {Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28186644}
}
Start for free →